FDA OKs diabetes drug combo Jentadueto

01/30/2012 | Wall Street Journal, The

Eli Lilly and Co. and Boehringer Ingelheim received FDA approval for Jentadueto, a type 2 diabetes medicine intended for use with exercise and diet. The oral treatment, which combines linagliptin and metformin hydrochloride, can be taken alone or with commonly prescribed sulfonylurea.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD